Christopher Golis

Christopher Golis has a diverse work experience spanning many years. Christopher currently holds the position of Vice President, Quality Assurance at Corcept Therapeutics, where they began working in July 2021. In the same company, they also briefly served as the Director of Legal in July 2021.

Prior to their current role, Christopher worked at Gilead Sciences for a significant period. Starting in February 2009, they held various roles within the legal department, including Senior Counsel, Director of Legal Investigations, and Senior Counsel II / Director of Litigation & Investigations. Christopher provided legal support on matters such as healthcare law, compliance, litigation, investigations, and policy development. Christopher's tenure at Gilead Sciences ended in June 2021.

Before joining Gilead Sciences, Christopher worked at Wilson Sonsini Goodrich & Rosati as an Associate in IP Litigation from October 2006 to February 2009.

Christopher began their career as an Intern at Panttaja Consulting from an unspecified start date until 1998.

Overall, Christopher Golis has extensive experience in legal and investigative roles within the biopharmaceutical industry, focusing on healthcare law, compliance, litigation, and policy development.

Christopher Golis attended Santa Rosa High School from 1996 to 1999. Christopher then went on to obtain a Bachelor of Science degree in Microbiology, Immunology, and Molecular Genetics from UCLA, graduating in 2003. Golis continued their education at Georgetown University Law Center, where they earned a JD degree between 2003 and 2006.